Login Register
English
0

Cart

$ 0

Roflupram, a novel phosphodiesterase 4 inhibitor, inhibits lipopolysaccharide-induced neuroinflammatory responses through activation of the AMPK/Sirt1 pathway(A23220-5.1)

Date:2021-04-07 Views:5